Drug recall · June 10, 2026
Lidocaine HCl Injection recall
Why: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
- Lots / codes
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
- Quantity
- 168,300 vials
- Company
- Eugia US LLC, East Windsor, NJ
- Distribution
- US Nationwide.
- Initiated
- May 18, 2026 · Voluntary: Firm initiated
- Classified
- May 29, 2026
- Reported
- June 10, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.